SDX 0.00% 7.0¢ sienna cancer diagnostics limited

News: SDX Sienna Cancer Diagnostics Says Entered Exclusive Licence Agreement To Develop Unique...

  1. 190,166 Posts.
    lightbulb Created with Sketch. 2787

    April 20 (Reuters) - Sienna Cancer Diagnostics Ltd (SDX) :

    • SIENNA CANCER DIAGNOSTICS- ENTERED EXCLUSIVE WORLDWIDE LICENCE AGREEMENT WITH UNIVERSITY OF ADELAIDE TO DEVELOP & COMMERCIALISE UNIQUE CANCER PROBE
 
watchlist Created with Sketch. Add SDX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.